Skip to main content

Table 2 Demographic characteristics of women in the study separated by treatment arm for those with histology available

From: Artemether-lumefantrine to treat malaria in pregnancy is associated with reduced placental haemozoin deposition compared to quinine in a randomized controlled trial

  

Quinine

AL

p

Age (y)

Mean (SD); n

22.7 (4.6); 97

23.1 (5.3); 98

0.583

Parity

Median [range]; n

1 [0-6]; 97

1 [0-7]; 98

0.818

Gravidity

Median [range]; n

2 [1-7]; 97

2 [1-8]; 98

0.917

Birth weight (kg)

Mean (SD); n

3.02 (0.50); 85

3.06 (0.45); 84

0.525

EGA enrolment (weeks)

Mean (SD); n

23.7 (6.7); 96

24.0 (7.6); 98

0.800

Parasitaemia (per L)

Geometric mean [IQR]; n

2,006 [205-5,029]; 97

1,191 [504-10,335]; 97

0.075

EGA delivery (weeks)

Mean (SD); n

39.0 (3.8); 96

39.4 (2.9); 96

0.475

Days between treatment and delivery

Median [range]; n

105 [1-192]; 97

91 [1-204]; 98

0.994

Haemoglobin (g/dL)

Mean (SD); n

12.1 (2.4); 82

12.0 (1.9); 87

0.728

  1. AL- artemether-lumefantrine; EGA- estimated gestational age; IQR interquartile range.